Cerebrospinal fluid tau levels increase with age in healthy individuals

被引:40
作者
Blomberg, M [1 ]
Jensen, M [1 ]
Basun, H [1 ]
Lannfelt, L [1 ]
Wahlund, LO [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Geriatr Med,NEUROTEC, Dept Clin Neurosci Occupat Therapy & Elderly Care, S-14186 Huddinge, Sweden
关键词
tau protein; cerebrospinal fluid; apolipoprotein E; genotype; Alzheimer's disease;
D O I
10.1159/000051246
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cerebrospinal fluid (CSF) tau is a promising biochemical ante-mortem marker for Alzheimer's disease (AD). Levels are increased in AD compared to other dementias, neurological diseases and healthy controls. An age-related decrease in both soluble tau and tau bound to paired helical filaments has been shown in brains from non-demented subjects. To study tau levels in normal ageing, we investigated CSF in 29 healthy individuals aged 45-80 years, A statistically significant increase in CSF tau with increasing age was found which might be caused by neuronal loss during normal ageing and redistribution of soluble tau from the brain into CSF, We could not demonstrate any influence by the APOE genotype, though larger populations have to be investigated to confirm this result. in conclusion, we found an age-dependent increase in CSF tau in healthy individuals, We emphasise the importance of establishing an age-dependent interval of CSF tau in non-demented subjects. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 32 条
[1]  
Arai H, 1997, GERONTOLOGY, V43, P2
[2]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[3]   Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more [J].
Basun, H ;
Corder, EH ;
Guo, Z ;
Lannfelt, L ;
Corder, LS ;
Manton, KG ;
Winblad, B ;
Viitanen, M .
STROKE, 1996, 27 (08) :1310-1315
[4]   tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease? [J].
Blennow, K ;
Wallin, A ;
Agren, H ;
Spenger, C ;
Siegfried, J ;
Vanmechelen, E .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) :231-245
[5]   Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up [J].
Blomberg, M ;
Jensen, M ;
Basun, H ;
Lannfelt, L ;
Wahlund, LO .
NEUROSCIENCE LETTERS, 1996, 214 (2-3) :163-166
[6]   Age-Associated Memory Impairment: Proposed Diagnostic Criteria and Measures of Clinical Change - Report of a National Institute of Mental Health Work Group [J].
Crook, Thomas ;
Bartus, Raymond T. ;
Ferris, Steven H. ;
Whitehouse, Peter ;
Cohen, Gene D. ;
Gershon, Samuel .
DEVELOPMENTAL NEUROPSYCHOLOGY, 1986, 2 (04) :261-276
[7]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[8]   Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease [J].
Galasko, D ;
Clark, C ;
Chang, L ;
Miller, B ;
Green, RC ;
Motter, R ;
Seubert, P .
NEUROLOGY, 1997, 48 (03) :632-635
[9]  
GOLOMBOWSKI S, 1997, NEUROSCI LETT, V267, P65
[10]   CELL COUNTS IN HUMAN CEREBRAL-CORTEX IN NORMAL ADULTS THROUGHOUT LIFE USING AN IMAGE ANALYZING COMPUTER [J].
HENDERSON, G ;
TOMLINSON, BE ;
GIBSON, PH .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1980, 46 (01) :113-136